Treatment of Lung Metastases from Ewing Sarcoma with Stereotactic Body Radiotherapy rather than Whole-Lung Irradiation

JOURNAL TITLE: Journal of Postgraduate Medicine, Education and Research

Author
1. William Read
2. Ajay Sandhu
3. Douglas A Rahn
ISSN
2277-8969
DOI
10.5005/jp-journals-10028-1008
Volume
46
Issue
1
Publishing Year
2012
Pages
3
Author Affiliations
    1. Department of Radiation Oncology, University of California San Diego, USA
    1. Department of Medical Oncology, Imory University, Georgia, USA
  • Article keywords

    Abstract

    Advances in knowledge

    Lung metastases from Ewing sarcoma have traditionally been treated with whole-lung irradiation (WLI) and chemotherapy. WLI may unnecessarily treat uninvolved normal lung tissue and increase the risk of toxicity. Stereotactic body radiotherapy (SBRT) has proven to be a safe and effective treatment for primary lung cancer and lung metastases, but there is no significant published description of SBRT in lung metastases from Ewing sarcoma.

    Implications for patient care

    The patient presented in this case report had long-term survival from lung metastases of Ewing sarcoma treated with chemotherapy and SBRT. SBRT may prove to be safer and more effective than whole lung irradiation as a treatment of lung metastases in Ewing sarcoma.

    Summary statement

    Whether SBRT of lung metastases of Ewing sarcoma can improve outcomes and decrease toxicity compared to whole-lung irradiation, surgical resection or palliative chemotherapy merits further study.

    How to cite this article

    Rahn DA, Read W, Sandhu A. Treatment of Lung Metastases from Ewing Sarcoma with Stereotactic Body Radiotherapy rather than Whole-Lung Irradiation. J Postgrad Med Edu Res 2012;46(1):34-36.

    © 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved